Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Pharmacogenet Genomics. 2016 Nov;26(11):510–516. doi: 10.1097/FPC.0000000000000244

Table 1.

Cohort Characteristics

European-Americans
(N = 943)
African-Americans
(N = 140)
Overall
(N = 1083)
Age (years) 67.0 (45.0, 83.8) 60.5 (32.0, 79.0) 67.0 (43.0, 83.0)
Gender (female) 42.7 57.1 44.6
BMI (kg/m2) 28.2 (22.2, 38.0) 30.3 (22.5, 43.1) 28.4 (22.2, 38.3)
Current smokers 9.8 21.4 11.3
Amiodarone use 8.3 8.6 8.3
Enzyme inducers 2.7 2.9 2.7
Indication for
warfarin
  Atrial fibrillation 56.5 31.4 53.3
  Thrombosis 22.4 49.3 25.9
  Stroke 5.4 5.0 5.4
  Orthopedic 0.2 0.7 0.3
  Other 17.3 15.0 17.0

Continuous variables are shown as 10th, 50th and 90th percentiles. Categorical variables are shown as percentages